Title : Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study - Ceccanti_2022_Front.Pharmacol_13_982434 |
Author(s) : Ceccanti M , Libonati L , Ruffolo G , Cifelli P , Moret F , Frasca V , Palma E , Inghilleri M , Cambieri C |
Ref : Front Pharmacol , 13 :982434 , 2022 |
Abstract : |
PubMedSearch : Ceccanti_2022_Front.Pharmacol_13_982434 |
PubMedID: 36052140 |
Title : Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study - Ceccanti_2022_Front.Pharmacol_13_982434 |
Author(s) : Ceccanti M , Libonati L , Ruffolo G , Cifelli P , Moret F , Frasca V , Palma E , Inghilleri M , Cambieri C |
Ref : Front Pharmacol , 13 :982434 , 2022 |
Abstract : |
PubMedSearch : Ceccanti_2022_Front.Pharmacol_13_982434 |
PubMedID: 36052140 |